Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by 18tee20on Jun 06, 2013 11:30am
228 Views
Post# 21492543

RE: RE: Stop Gap

RE: RE: Stop Gap

"The question in my mind is why did RCP give up the best loan it ever gave out?"

Your answer is given right in the news release. 

RCP didn't give up on the loan, rather Bioniche terminated the loan early and paid formerly agreed upon early breakuup penalties to do so.  I doubt RCP had any choice in the matter, but was able to keep the 2% royalty, which was also probably in the original loan agreement as part of any early prepayment penalty.

"Paladin today acquired Bioniche's existing debt facility with Capital Royalty Partners II L.P. and its affiliates for approximately $22 million (including accrued interest and prepayment penalties)."

<< Previous
Bullboard Posts
Next >>